Clinical trial
Bioavailability and Effectiveness of Transdermally Administered Morphine
NCT00125684 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00125684 |
|---|---|
| Title | Bioavailability and Effectiveness of Transdermally Administered Morphine |
| Official title | Bioavailability and Effectiveness of Transdermally Administered Morphine |
| Lead sponsor | Alberta Health services, Other |
| Collaborators | Tom Baker Cancer Centre |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer, Pain |
| Intervention type | Drug |
| Interventions | morphine |
| Enrollment | 6 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Aug 2, 2005 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: